Aries Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.46M Sell
25,436
-50
-0.2% -$11.7K 1.27% 17
2026
Q1
$6.23M Sell
25,486
-60
-0.2% -$14K 1.37% 19
2025
Q4
$5.29M Hold
25,546
1.17% 22
2025
Q3
$4.74M Sell
25,546
-142
-0.6% -$24.3K 1.12% 22
2025
Q2
$3.92M Sell
25,688
-3,680
-13% -$566K 1.03% 26
2025
Q1
$4.87M Buy
29,368
+987
+3% +$154K 1.32% 17
2024
Q4
$4.1M Sell
28,381
-730
-3% -$113K 1.13% 23
2024
Q3
$4.72M Sell
29,111
-2,114
-7% -$337K 1.3% 18
2024
Q2
$4.56M Buy
31,225
+54
+0.2% +$8.03K 1.44% 17
2024
Q1
$4.93M Buy
31,171
+496
+2% +$78.9K 1.59% 13
2023
Q4
$4.81M Sell
30,675
-457
-1% -$70.1K 1.71% 13
2023
Q3
$4.9M Buy
31,132
+575
+2% +$94.9K 1.92% 10
2023
Q2
$5.06M Sell
30,557
-702
-2% -$113K 1.96% 9
2023
Q1
$4.85M Buy
31,259
+149
+0.5% +$24.1K 1.99% 9
2022
Q4
$5.5M Buy
31,110
+125
+0.4% +$21.6K 2.37% 6
2022
Q3
$5.39M Buy
30,985
+273
+0.9% +$46.2K 2.39% 7
2022
Q2
$5.45M Buy
+30,712
New +$5.47M 2.48% 7
2022
Q1
Sell
-29,768
Closed -$5.09M 146
2021
Q4
$5.09M Buy
29,768
+684
+2% +$112K 1.94% 11
2021
Q3
$4.7M Buy
29,084
+377
+1% +$64.3K 1.99% 11
2021
Q2
$4.73M Buy
28,707
+514
+2% +$85.1K 2.02% 10
2021
Q1
$4.51M Sell
28,193
-161
-0.6% -$26.1K 2.03% 11
2020
Q4
$4.54M Sell
28,354
-195
-0.7% -$28.8K 2.27% 10
2020
Q3
$4.25M Buy
28,549
+110
+0.4% +$16.3K 2.41% 8
2020
Q2
$4M Buy
28,439
+422
+2% +$61.5K 2.44% 7
2020
Q1
$3.73M Buy
28,017
+85
+0.3% +$12.1K 2.84% 4
2019
Q4
$4.03M Buy
27,932
+75
+0.3% +$10.2K 2.46% 8
2019
Q3
$3.66M Sell
27,857
-566
-2% -$74.6K 2.43% 8
2019
Q2
$4M Sell
28,423
-33
-0.1% -$4.57K 2.79% 7
2019
Q1
$3.98M Buy
28,456
+14,559
+105% +$1.95M 2.97% 5
2018
Q4
$1.79M Buy
13,897
+102
+0.7% +$14.2K 1.9% 13
2018
Q3
$1.91M Hold
13,795
1.71% 13
2018
Q2
$1.83M Sell
13,795
-950
-6% -$119K 1.69% 15
2018
Q1
$1.92M Buy
14,745
+90
+0.6% +$12.2K 1.86% 13
2017
Q4
$2.16M Buy
+14,655
New +$2.04M 1.99% 10

Other funds holding JNJ

Aries Wealth Management's JNJ Position: Q2 2026 in Review

Aries Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.2% in Q2 2026, selling an estimated $11.7K and leaving 25,436 shares worth $6.46M. The position accounts for 1.27% of the portfolio, ranked #17.

Aries Wealth Management first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Aries Wealth Management held 25,436 shares of Johnson & Johnson worth $6.46M as of Q2 2026.
  • Aries Wealth Management sold 50 Johnson & Johnson shares in Q2 2026, an estimated $11.7K.
  • Johnson & Johnson made up 1.27% of Aries Wealth Management's portfolio in Q2 2026, its #17 holding.
  • Aries Wealth Management first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Aries Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.